Memantine Treatment Study of Pathological Gambling
NCT00585169
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
29
Enrollment
OTHER
Sponsor class
Conditions
Pathological Gambling
Interventions
DRUG:
Memantine Hydrochloride
Sponsor
Yale University
Collaborators
[object Object]
[object Object]